Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc.SHPH · Entity 8505 | Director | December 31, 2024 | February 05, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Shuttle Pharmaceuticals Holdings, Inc.
Report date December 31, 2024 · Filed February 05, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 346,617 |
Reported balance
After 2024-12-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-12-23 · Grant · Acquired 209,790 · Balance 346,617 F1: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2: Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027.
F2: Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2024 Filed Feb 5, 2025 16:55 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantCommon Stock | 209,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-005035 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,617 F1 · shares: Represents 209,790 restricted stock units ("RSUs") issued to the Reporting Person under the Shuttle Pharmaceuticals Holdings, Inc. 2018 Equity Incentive Plan. The 209,790 RSUs which are scheduled to vest in one third increments on each of 12/31/2025, 12/31/2026 and 12/31/2027. F2 · balance_after: Consists of (1) 135,785 shares of common stock and (2) 210,832 RSUs, which remain subject to vesting. Read SEC document |
| December 13, 2023 Filed Jan 2, 2024 17:10 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | SaleCommon Stock | 2,921 | $0.46 | $1,353.01 |
DisclosureSEC source: 0001493152-24-000125 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,094,610 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of (i) 1,077,943 shares of common stock and (ii) 16,667 RSUs which remain subject to certain vesting conditions. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 08:29 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | GrantStock Options · Derivative | 25,000 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001493152-23-005375 · ownership.xml · derivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2028-02-15 F1 · balance_after: The Reporting Person received 25,000 stock options ("Stock Options") to purchase shares of SHPH common stock on February 15, 2023, which Stock Options vest in full on the first anniversary of the date of grant. Read SEC document |
| December 29, 2022 Filed Jan 4, 2023 16:10 UTC | Shuttle Pharmaceuticals Holdings, Inc. SHPH · Entity 8505 | SaleCOMMON STOCK | 995 | $1.61 | $1,596.98 |
DisclosureSEC source: 0001493152-23-000318 · ownership.xml · nonDerivative · entry 1 Brown Milton · CIK 0001945206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,531 F1 · shares: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 2,702 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. F2 · balance_after: Consists of 1,072,531 shares of SHPH common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.